Affiliation:
1. The State Budgetary Institution of Higher Professional Education Voronezh State Medical University named after N.N.Burdenko of the Ministry of Public Health
of the Russian Federation
2. I.M.Sechenov First Moscow State Medical University (Sechenov University)
3. The State Budgetary Institution of Higher Professional Education Voronezh State Medical University named after N.N.Burdenko of the Ministry of Public Health
of the Russian Federation; Research Institute of Experimental Biology and Medicine, The State Budgetary Institution of Higher Professional Education Voronezh State Medical University named after N.N.Burdenko of the Ministry of Public Health of the Russian Federation
Abstract
Chronic obstructive pulmonary disease (COPD) is one of major causes of chronic noncommunicable diseases and mortality worldwide. The roles of macrophages, T-lymphocytes, neutrophils, and other cells in the development of chronic inflammation in this disease are well studied, but more and more researchers have focused on mast cells (MC) in recent years.The aim of this work is to summarize the data of experimental and clinical studies on the possible role of MCs in the pathogenesis of COPD. To this end, the review analyzed data on the relationship between MCs and respiratory function parameters in COPD, as well as the distribution of MCs subpopulations in different parts of the respiratory tract. The involvement of proteases (chymase and tryptase) in the development of inflammatory and fibrotic changes in COPD is discussed. The review presents research findings that indicate the possible involvement of chymase in pulmonary artery remodeling, increased secretion of mucins, and slowing down the airway epithelial repair. The role of MC tryptase in the development of fibrotic changes in the lungs and airways in COPD is also highlighted. A separate section of the review is devoted to chemokines that promote MC migration and their specific receptor. Chemokines play a special role in the development of inflammation in COPD.Conclusion. The available data suggest that MCs play a major role in the pathogenesis of COPD. Because of the inconsistency of some results, further clinical studies in larger cohorts of patients are needed.
Publisher
Scientific and Practical Reviewed Journal Pulmonology
Subject
Pulmonary and Respiratory Medicine
Reference37 articles.
1. World Health Organization. The top 10 causes of death. Fact sheets. Available at: https://www.who.int/ru/news-room/fact-sheets/detail/the-top-10-causes-of-death [Accessed: January 31, 2020].
2. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. 2022 Report. Available at: https://goldcopd.org/wp-content/uploads/2021/12/GOLD-REPORT-2022-v1.1-22Nov2021_WMV.pdf [Accessed: January 31, 2021].
3. Budnevsky A.V., Isaeva Ya.V., Malysh E.Yu., Kozhevnikova S.A. [Pulmonary rehabilitation as an effective method for optimizing therapeutic and preventive measures in patients with chronic obstructive pulmonary disease concurrent with metabolic syndrome]. Terapevticheskiy arkhiv. 2016; 88 (8): 25–29. DOI: 10.17116/terarkh201688825-29 (in Russian).
4. Kozhevnikova S.A., Budnevsky A.V., Ovsyannikov E.S., Belov V.N. [Particularity of the clinical course and quality of life of patients with chronic obstructive pulmonary disease on the background of the metabolic syndrome]. Meditsinkiy vestnik Severnogo Kavkaza. 2017; 12 (1): 20–23. DOI: 10.14300/mnnc.2017.12006 (in Russian).
5. Provotorov V.M., Budnevsky A.V., Semenkova G.G., Shishkina E.S. [Proinflammatory cytokines in combination of coronary heart disease and chronic obstructive pulmonary disease]. Klinicheskaya meditsina. 2015; 93 (2): 5–9. Available at: https://cyberleninka.ru/article/n/provospalitelnye-tsitokiny-pri-sochetanii-ishemicheskoy-bolezni-serdtsa-i-hronicheskoy-obstruktivnoy-bolezni-legkih/viewer (in Russian).